These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 23188156)

  • 1. Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines.
    Lavanya M; Lin C; Mao J; Thirumalai D; Aabaka SR; Yang X; Mao J; Huang Z; Zhao J
    Top Curr Chem (Cham); 2021 Feb; 379(2):13. PubMed ID: 33624162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 8-Amino-Substituted 2-Phenyl-2,7-Naphthyridinone Derivatives as New c-Kit/VEGFR-2 Kinase Inhibitors.
    Sun H; Zhuo L; Dong H; Huang W; She N
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent 1H-imidazo[4,5-b]pyridine-based c-Met kinase inhibitors via mechanism-directed structural optimization.
    An XD; Liu H; Xu ZL; Jin Y; Peng X; Yao YM; Geng M; Long YQ
    Bioorg Med Chem Lett; 2015 Feb; 25(3):708-16. PubMed ID: 25529740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel substituted naphthyridines as potential c-Met kinase inhibitors based on MK-2461.
    Wu JF; Liu MM; Huang SX; Wang Y
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3251-5. PubMed ID: 26077488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of new MET inhibitors with 1,6-naphthyridinone scaffold.
    Wang MS; Zhuo LS; Yang FP; Wang WJ; Huang W; Yang GF
    Eur J Med Chem; 2020 Jan; 185():111803. PubMed ID: 31677447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors.
    Zhang D; Ai J; Liang Z; Li C; Peng X; Ji Y; Jiang H; Geng M; Luo C; Liu H
    Bioorg Med Chem; 2012 Sep; 20(17):5169-80. PubMed ID: 22863529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors.
    She N; Zhuo L; Jiang W; Zhu X; Wang J; Ming Z; Zhao X; Cong X; Huang W
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3351-5. PubMed ID: 24951334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the 1,6-naphthyridine motif: discovery and SAR study of 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one-based c-Met kinase inhibitors.
    Wang Y; Xu ZL; Ai J; Peng X; Lin JP; Ji YC; Geng MY; Long YQ
    Org Biomol Chem; 2013 Mar; 11(9):1545-62. PubMed ID: 23188156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,6-Naphthyridin-2(1
    Oliveras JM; Puig de la Bellacasa R; Estrada-Tejedor R; Teixidó J; Borrell JI
    Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681253
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.